Aker BioMarine AS (OSL:AKBM)
66.70
+1.80 (2.77%)
Feb 21, 2025, 4:25 PM CET
Aker BioMarine AS Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Net Income | 181.5 | -9 | 10 | -8 | -5.46 | Upgrade
|
Depreciation & Amortization | 44.9 | 48.8 | 49.2 | 51 | 47.41 | Upgrade
|
Other Amortization | - | 3.5 | 2.2 | 2 | 0.83 | Upgrade
|
Asset Writedown & Restructuring Costs | - | 0.5 | - | 5.8 | 0.04 | Upgrade
|
Loss (Gain) on Equity Investments | - | 3 | - | - | - | Upgrade
|
Other Operating Activities | -224.6 | -22.4 | -8.3 | -16.6 | -14.43 | Upgrade
|
Change in Accounts Receivable | - | 23 | -38 | -31.6 | -29.44 | Upgrade
|
Change in Inventory | - | - | - | - | -20.55 | Upgrade
|
Change in Other Net Operating Assets | 10.4 | - | - | - | -29.46 | Upgrade
|
Operating Cash Flow | 12.2 | 47.4 | 15.1 | 2.6 | -51.04 | Upgrade
|
Operating Cash Flow Growth | -74.26% | 213.91% | 480.77% | - | - | Upgrade
|
Capital Expenditures | -20.4 | -45.9 | -40.5 | -78.7 | -21.65 | Upgrade
|
Sale of Property, Plant & Equipment | 404.1 | 0.6 | - | - | 22.01 | Upgrade
|
Cash Acquisitions | - | - | -11.1 | - | -0.36 | Upgrade
|
Sale (Purchase) of Intangibles | -2.6 | -3.4 | -5.6 | -2.4 | -2.06 | Upgrade
|
Other Investing Activities | -1.8 | 0.1 | - | - | - | Upgrade
|
Investing Cash Flow | 379.3 | -48.9 | -56.4 | -81.1 | -2.05 | Upgrade
|
Long-Term Debt Issued | 150.7 | 40 | 66.5 | 339.2 | 33 | Upgrade
|
Total Debt Issued | 150.7 | 40 | 66.5 | 339.2 | 33 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -16.46 | Upgrade
|
Long-Term Debt Repaid | -181.5 | -33.3 | -14.2 | -260.3 | -190.55 | Upgrade
|
Total Debt Repaid | -181.5 | -33.3 | -14.2 | -260.3 | -207.01 | Upgrade
|
Net Debt Issued (Repaid) | -30.8 | 6.7 | 52.3 | 78.9 | -174.01 | Upgrade
|
Issuance of Common Stock | - | - | 0.2 | - | 224.18 | Upgrade
|
Common Dividends Paid | -373.2 | - | - | - | - | Upgrade
|
Other Financing Activities | - | - | - | - | -0 | Upgrade
|
Financing Cash Flow | -404 | 6.7 | 52.5 | 78.9 | 50.16 | Upgrade
|
Net Cash Flow | -12.5 | 5.2 | 11.2 | 0.4 | -2.93 | Upgrade
|
Free Cash Flow | -8.2 | 1.5 | -25.4 | -76.1 | -72.7 | Upgrade
|
Free Cash Flow Margin | -4.12% | 0.45% | -9.16% | -29.03% | -25.19% | Upgrade
|
Free Cash Flow Per Share | - | 0.02 | -0.29 | -0.87 | -0.93 | Upgrade
|
Cash Interest Paid | 19.9 | 29.7 | 17.6 | 12.8 | 30.75 | Upgrade
|
Cash Income Tax Paid | - | 0.7 | 2.8 | -3.3 | 2.33 | Upgrade
|
Levered Free Cash Flow | 70.78 | 6.35 | -34.7 | -49.05 | -38.45 | Upgrade
|
Unlevered Free Cash Flow | 75.78 | 27.23 | -22.01 | -40.49 | -26.74 | Upgrade
|
Change in Net Working Capital | -58 | -20.6 | 37.5 | 8.08 | 56.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.